STOCK TITAN

Pfizer Inc. - PFE STOCK NEWS

Welcome to our dedicated news page for Pfizer (Ticker: PFE), a resource for investors and traders seeking the latest updates and insights on Pfizer.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Pfizer's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Pfizer's position in the market.

Rhea-AI Summary
Flagship Pioneering and Pfizer have partnered to invest $100M upfront in exploring opportunities to develop 10 single-asset programs within Pfizer's core strategic areas of interest. Pioneering Medicines, an initiative of Flagship Pioneering, will lead the exploration process.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.06%
Tags
partnership
-
Rhea-AI Summary
Pfizer and OPKO Health announce FDA approval for NGENLA, a once-weekly treatment for children with growth hormone deficiency. NGENLA is expected to be available for prescribing in the US in August 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.61%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.68%
Tags
-
Rhea-AI Summary
Pfizer receives FDA approval for LITFULO, the first and only treatment for severe alopecia areata in patients as young as 12.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
dividends
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.12%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.8%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.72%
Tags
conferences
Pfizer Inc.

NYSE:PFE

PFE Rankings

PFE Stock Data

153.91B
5.64B
0.05%
69.93%
1.15%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
NEW YORK

About PFE

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.